Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-23

Clinical Trial Update: ASPirin Intervention for the REDuction of Colorectal Cancer Risk [NA]

View source ↗

Summary

Update on a Massachusetts General Hospital trial evaluating aspirin to reduce colorectal cancer risk. Results were posted in March 2021, and the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Colorectal Cancer | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-03-23